Pancreatic neuroendocrine neoplasms: a 2022 update for radiologists.
Samuel J GalganoAjaykumar C MoraniDheeraj R GopireddyKedar SharbidreDavid D B BatesAjit H GoenkaHina Arif-TiwariMalak ItaniAmir IravaniSanaz JavadiSilvana FariaChandana LallEmily BergslandSadhna VermaIsaac R FrancisDaniel M HalperinDeyali ChatterjeePriya BhosaleMotoyo YanoPublished in: Abdominal radiology (New York) (2022)
Pancreatic neuroendocrine neoplasms (PaNENs) are a unique group of pancreatic neoplasms with a wide range of clinical presentations and behaviors. Given their heterogeneous appearance and increasing detection on cross-sectional imaging, it is essential that radiologists understand the variable presentation and distinctions PaNENs display compared to other pancreatic neoplasms. Additionally, some of these neoplasms may be hormonally functional, and it is imperative that radiologists be aware of the common clinical presentations of hormonally active PaNENs. Knowledge of PaNEN pathology and treatments may influence which imaging modality is optimal for each patient. Each imaging modality used for PaNENs has distinct advantages and disadvantages, particularly in different treatment settings. Thus, the focus of this manuscript is to provide an update for the radiologist on PaNEN pathology, imaging, and treatments.